NCT00874302 · Interventional trial
Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms
Overall registry status Withdrawn
Phase 3
Conditions Uterine Fibroids
Delaware Valley sites
- Thomas Jefferson University - Jefferson Center for Women's Medical Specialties · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory